COVID-19 is more lethal in hemodialysis chronic kidney disease patients with low physical capacity

被引:2
|
作者
Orcy, Rafael B. [1 ,2 ,6 ]
Bluhm, Caroline C. [1 ]
Ribeiro, Larissa R. [3 ]
Sosa, Priscila M. [4 ]
Correa, Bianca D. [4 ]
Barcellos, Franklin C. [5 ]
Bohlke, Maristela [3 ,5 ]
机构
[1] Univ Fed Pelotas, Postgrad Programme Phys Educ, Pelotas, Brazil
[2] Fed Univ Pelota, Multictr Postgrad Programme Physiol Sci, Pelotas, Brazil
[3] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, Brazil
[4] Univ Fed Pelotas, Higher Sch Phys Educ & Physiotherapy, Pelotas, Brazil
[5] Sao Francisco Paula Univ Hosp, Dialysis & Kidney Transplantat Unit, Pelotas, Brazil
[6] 625 Luis Camoes St, BR-96055630 Pelotas, Brazil
关键词
COVID-19; functional capacity; hemodialysis patients; 6-MINUTE WALK TEST; OLDER-ADULTS; MORTALITY; STRENGTH; SURVIVAL; DISTANCE;
D O I
10.1111/1744-9987.14069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The mortality rate in patients on maintenance hemodialysis (HD) is high and is associated with low functional capacity (FC). We analyzed the association of FC and COVID-19 lethality among HD patients. Methods: A cohort study that included evaluations of FC in patients on HD was underway, and the association between FC and lethality was included as an ad-hoc outcome. Results: One hundred and twelve patients were submitted to a physical, 31 patients contracted symptomatic COVID-19, 20 recovered and 11 died (lethality rate of 35.5%). There was a difference between survivors and non-survivors on six-minutes-walking-test (6MWT) 386.1 +/- 112.8 versus 296.9 +/- 103.3 meters (p = 0.04), 30 s sit-to-stand test (30CST) score 11.7 +/- 3.1 versus 7.7 +/- 4.1 (p = 0.006), and timed up and go test (TUG) 9.4 versus 13.6 s (p = 0.009). There was also an association between percentages of predicted 6MWT, 30CST, and TUG with COVID-19 lethality. Conclusion: Patients on maintenance HD with poorer physical performance presented the worst prognosis from COVID-19 pandemic.
引用
收藏
页码:61 / 68
页数:8
相关论文
共 50 条
  • [1] Sequels of COVID-19 in nephrology. Chronic kidney patients are more prone to hemodialysis need and mortality
    Bolleku, Erjola
    Likaj, Ermal
    Shehaj, Larisa
    Akshija, Ilir
    Puca, Edmond
    Puca, Entela
    Baci, Xhesi
    Idrizi, Alma
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2024, 18 (12): : S331 - S336
  • [2] Lethal Covid-19 in two vaccinated hemodialysis patients
    Quiroga, Borja
    Cabrera Cardenas, Alicia
    Ruano, Pablo
    THERAPEUTIC APHERESIS AND DIALYSIS, 2022, 26 (01) : 246 - 247
  • [3] COVID-19 and cardiovascular disease in patients with chronic kidney disease
    Del Vecchio, Lucia
    Balafa, Olga
    Dounousi, Evangelia
    Ekart, Robert
    Fernandez, Beatriz Fernandez
    Mark, Patrick B.
    Sarafidis, Pantelis
    Valdivielso, Jose M.
    Ferro, Charles J.
    Mallamaci, Francesca
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (02) : 177 - 189
  • [4] COVID-19 and chronic kidney disease
    Trevino-Becerra, Alejandro
    Grajales-Garcia, Dulce P.
    Feria Ramirez, Jose A.
    GACETA MEDICA DE MEXICO, 2022, 158 : 45 - 47
  • [5] COVID 19 IMPAIRS ENDOTHELIAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON HEMODIALYSIS
    Carlos Santos, Juan
    Mabel Lepera, Rosa
    Fernandez Serra, Rocio
    Lossi, Susana
    Alanoca, Saul
    Joo Turoni, Claudio
    Peral de Bruno, Maria
    Oscar Maranon, Rodrigo
    JOURNAL OF HYPERTENSION, 2023, 41 : E387 - E388
  • [6] Remdesivir in Patients with Acute or Chronic Kidney Disease and COVID-19
    Adamsick, Meagan L.
    Gandhi, Ronak G.
    Bidell, Monique R.
    Elshaboury, Ramy H.
    Bhattacharyya, Roby P.
    Kim, Arthur Y.
    Nigwekar, Sagar
    Rhee, Eugene P.
    Sise, Meghan E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (07): : 1384 - 1386
  • [7] Anticoagulation therapy in COVID-19 patients with chronic kidney disease
    Shafiee, Mohammad Ali
    Hosseini, Sayyideh Forough
    Mortazavi, Mojgan
    Emami, Anahita
    Zadeh, Mahtab Mojtahed
    Moradi, Sanaz
    Shaker, Pouyan
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2021, 26 (01):
  • [8] The impact of chronic kidney disease in diabetic COVID-19 patients
    Chaabouni, Hana
    Bougharriou, Ichrak
    Mnif, Khouloud
    Maazoun, Majdi
    Ben Jemaa, Tarak
    Rekik, Khaoula
    Smaoui, Fatma
    Koubaa, Makram
    Marrakchi, Chakib
    Hammami, Boussayma
    Ben Jemaa, Mounir
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 128 : S33 - S33
  • [9] Paxlovid for hospitalized COVID-19 patients with chronic kidney disease
    Cai, Hong
    Yan, Jiayi
    Liu, Shang
    Li, Ping
    Ding, Li
    Zhan, Yaping
    Lu, Jiayue
    Li, Zhenyuan
    Sun, Yiwen
    Zhu, Mingli
    Gao, Yuan
    Gong, Xingrong
    Ban, Haiqun
    Gu, Leyi
    Zhou, Weibin
    Wang, Jieying
    Mou, Shan
    ANTIVIRAL RESEARCH, 2023, 216
  • [10] COVID-19 in Patients with Kidney Disease
    Ajaimy, Maria
    Melamed, Michal L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (08): : 1087 - 1089